Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Reports of Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Reports of Exempt Distribution

KOO-KOO2

Feb 04, 2023 09:01AM

Re: Reports of Exempt Distribution

Temsamany

Feb 06, 2023 11:59AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Reports of Exempt Distribution

in response to

Re: Reports of Exempt Distribution

Temsamany

posted on Feb 06, 2023 12:53PM

Yes, pretty much all of them, with the odd exception.

One in Jan 2023 (part of a group) for 6,600 common shares @ $1.34 plus share purchase warrants exercise price of $1.34 expiry date 2023-11-14.

Koo

1 Recommendations

Re: Reports of Exempt Distribution

narmac

Feb 09, 2023 07:23AM

Re: Reports of Exempt Distribution

KOO-KOO2

Feb 09, 2023 08:01AM

Re: Reports of Exempt Distribution

narmac

Feb 09, 2023 08:30AM

Re: Reports of Exempt Distribution

KOO-KOO2

Feb 09, 2023 08:54AM

Re: Reports of Exempt Distribution

KayakerBC

Feb 09, 2023 10:08AM

Re: Reports of Exempt Distribution

KOO-KOO2

Feb 21, 2023 12:58PM

Re: Reports of Exempt Distribution

Toinv

Feb 22, 2023 09:43AM

Re: Reports of Exempt Distribution

jonzobot

Feb 23, 2023 02:56PM

Re: Reports of Exempt Distribution

KOO-KOO2

Feb 23, 2023 05:05PM

Re: Reports of Exempt Distribution

Toinv

Feb 24, 2023 10:39AM